Related Experiment Video
Updated: Dec 6, 2025
07:56
Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome
Published on: November 30, 2022
5.6K
Mitophagy: A Novel Therapeutic Target for Treating DN
Ming Yang1, Chenrui Li1, Shikun Yang2
1Department of Nephrology, The Second Xiangya Hospital Central South University, Hunan Key Laboratory of Kidney Disease and Blood Purification, No. 139 Renmin Middle Road, Changsha, Hunan, China.
Current Medicinal Chemistry
|October 7, 2020
Summary
Diabetic nephropathy (DN) involves tubular damage and mitochondrial issues. Enhancing mitophagy, the process of removing damaged mitochondria, may offer a new therapeutic strategy for DN.
Area of Science:
- Nephrology
- Cell Biology
- Metabolic Diseases
Background:
- Diabetic nephropathy (DN) is a major complication of diabetes, leading to kidney failure.
- Tubular damage and mitochondrial dysfunction are key early events in DN pathogenesis.
- Effective treatments for DN are urgently needed.
Purpose of the Study:
- To review the role of mitochondrial dysfunction in DN.
- To elucidate the molecular mechanisms of mitophagy in tubular cells.
- To discuss mitophagy as a potential therapeutic target for DN.
Main Methods:
- Literature review of studies on DN, mitochondrial dysfunction, and mitophagy.
- Analysis of molecular pathways involved in mitophagy.
- Discussion of preclinical and clinical evidence.
Main Results:
- Mitochondrial dysfunction significantly contributes to tubular injury in DN.
- Mitophagy selectively removes damaged mitochondria, protecting tubular cells from oxidative stress.
- Dysregulation of mitophagy is implicated in the progression of DN.
Conclusions:
- Targeting mitophagy presents a promising therapeutic strategy for diabetic nephropathy.
- Further research is warranted to explore the clinical feasibility of mitophagy modulation in DN treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
8.3K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.3K
01:46Electron Transport Chain: Complex I and II
17.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
17.5K
01:27Autophagy
5.5K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
01:36Delivery Pathways to the Lysosome
8.5K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.5K
01:18Autophagic Cell Death
4.0K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.0K